Logo image of ALSOG.PA

SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis

EPA:ALSOG - Euronext Paris - Matif - FR0000065864 - Common Stock - Currency: EUR

23.6  +0.3 (+1.29%)

Fundamental Rating

5

Taking everything into account, ALSOG scores 5 out of 10 in our fundamental rating. ALSOG was compared to 39 industry peers in the Aerospace & Defense industry. Both the profitability and the financial health of ALSOG get a neutral evaluation. Nothing too spectacular is happening here. ALSOG may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ALSOG was profitable.
In the past year ALSOG had a positive cash flow from operations.
ALSOG had positive earnings in 4 of the past 5 years.
In the past 5 years ALSOG always reported a positive cash flow from operatings.
ALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFALSOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

ALSOG has a worse Return On Assets (1.90%) than 64.10% of its industry peers.
ALSOG has a worse Return On Equity (6.40%) than 61.54% of its industry peers.
With a Return On Invested Capital value of 6.39%, ALSOG perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALSOG is below the industry average of 9.46%.
The 3 year average ROIC (5.72%) for ALSOG is below the current ROIC(6.39%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.9%
ROE 6.4%
ROIC 6.39%
ROA(3y)2.06%
ROA(5y)-0.15%
ROE(3y)6.53%
ROE(5y)-1.9%
ROIC(3y)5.72%
ROIC(5y)N/A
ALSOG.PA Yearly ROA, ROE, ROICALSOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

ALSOG has a worse Profit Margin (1.84%) than 66.67% of its industry peers.
ALSOG's Profit Margin has improved in the last couple of years.
The Operating Margin of ALSOG (4.00%) is worse than 71.79% of its industry peers.
In the last couple of years the Operating Margin of ALSOG has grown nicely.
The Gross Margin of ALSOG (54.60%) is better than 84.62% of its industry peers.
ALSOG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4%
PM (TTM) 1.84%
GM 54.6%
OM growth 3Y2.54%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALSOG.PA Yearly Profit, Operating, Gross MarginsALSOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40

4

2. Health

2.1 Basic Checks

ALSOG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALSOG remains at a similar level compared to 1 year ago.
ALSOG has a better debt/assets ratio than last year.
ALSOG.PA Yearly Shares OutstandingALSOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
ALSOG.PA Yearly Total Debt VS Total AssetsALSOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.23 indicates that ALSOG is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.23, ALSOG perfoms like the industry average, outperforming 51.28% of the companies in the same industry.
The Debt to FCF ratio of ALSOG is 9.11, which is on the high side as it means it would take ALSOG, 9.11 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 9.11, ALSOG is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.53 indicates that ALSOG is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, ALSOG is in the better half of the industry, outperforming 64.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 9.11
Altman-Z 2.23
ROIC/WACC0.88
WACC7.28%
ALSOG.PA Yearly LT Debt VS Equity VS FCFALSOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.59 indicates that ALSOG should not have too much problems paying its short term obligations.
ALSOG has a better Current ratio (1.59) than 82.05% of its industry peers.
ALSOG has a Quick Ratio of 1.36. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.36, ALSOG belongs to the top of the industry, outperforming 89.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.36
ALSOG.PA Yearly Current Assets VS Current LiabilitesALSOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.26% over the past year.
The Earnings Per Share has been growing by 18.79% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.07% in the past year.
ALSOG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.06% yearly.
EPS 1Y (TTM)42.26%
EPS 3Y18.79%
EPS 5YN/A
EPS Q2Q%41.66%
Revenue 1Y (TTM)6.07%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%3.24%

3.2 Future

Based on estimates for the next years, ALSOG will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.67% on average per year.
Based on estimates for the next years, ALSOG will show a small growth in Revenue. The Revenue will grow by 6.62% on average per year.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALSOG.PA Yearly Revenue VS EstimatesALSOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
ALSOG.PA Yearly EPS VS EstimatesALSOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4 -6

7

4. Valuation

4.1 Price/Earnings Ratio

ALSOG is valuated correctly with a Price/Earnings ratio of 16.28.
Based on the Price/Earnings ratio, ALSOG is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of ALSOG to the average of the S&P500 Index (24.21), we can say ALSOG is valued slightly cheaper.
ALSOG is valuated reasonably with a Price/Forward Earnings ratio of 10.27.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALSOG indicates a rather cheap valuation: ALSOG is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, ALSOG is valued a bit cheaper.
Industry RankSector Rank
PE 16.28
Fwd PE 10.27
ALSOG.PA Price Earnings VS Forward Price EarningsALSOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALSOG indicates a rather cheap valuation: ALSOG is cheaper than 94.87% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, ALSOG is valued cheaply inside the industry as 89.74% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 20.7
EV/EBITDA 10.19
ALSOG.PA Per share dataALSOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALSOG's earnings are expected to grow with 19.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.61
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.12%, ALSOG is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.33, ALSOG pays a better dividend. On top of this ALSOG pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, ALSOG pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.12%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALSOG.PA Yearly Dividends per shareALSOG.PA Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

ALSOG pays out 100.39% of its income as dividend. This is not a sustainable payout ratio.
DP100.39%
EPS Next 2Y19.67%
EPS Next 3YN/A
ALSOG.PA Yearly Income VS Free CF VS DividendALSOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 0 10M -10M 20M
ALSOG.PA Dividend Payout.ALSOG.PA Dividend Payout, showing the Payout Ratio.ALSOG.PA Dividend Payout.PayoutRetained Earnings

SOGECLAIR

EPA:ALSOG (5/9/2025, 7:00:00 PM)

23.6

+0.3 (+1.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-16 2025-07-16
Inst Owners4.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap75.52M
Analysts86.67
Price Target28.05 (18.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.12%
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP100.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.28
Fwd PE 10.27
P/S 0.49
P/FCF 20.7
P/OCF 14.22
P/B 1.69
P/tB 3.44
EV/EBITDA 10.19
EPS(TTM)1.45
EY6.14%
EPS(NY)2.3
Fwd EY9.73%
FCF(TTM)1.14
FCFY4.83%
OCF(TTM)1.66
OCFY7.03%
SpS48.31
BVpS13.92
TBVpS6.86
PEG (NY)0.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.9%
ROE 6.4%
ROCE 7.4%
ROIC 6.39%
ROICexc 7.25%
ROICexgc 10.37%
OM 4%
PM (TTM) 1.84%
GM 54.6%
FCFM 2.36%
ROA(3y)2.06%
ROA(5y)-0.15%
ROE(3y)6.53%
ROE(5y)-1.9%
ROIC(3y)5.72%
ROIC(5y)N/A
ROICexc(3y)6.74%
ROICexc(5y)N/A
ROICexgc(3y)9.79%
ROICexgc(5y)N/A
ROCE(3y)6.64%
ROCE(5y)N/A
ROICexcg growth 3Y-7.47%
ROICexcg growth 5YN/A
ROICexc growth 3Y-2.42%
ROICexc growth 5YN/A
OM growth 3Y2.54%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score7
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 9.11
Debt/EBITDA 2.46
Cap/Depr 49.54%
Cap/Sales 1.08%
Interest Coverage 4.66
Cash Conversion 55.68%
Profit Quality 127.99%
Current Ratio 1.59
Quick Ratio 1.36
Altman-Z 2.23
F-Score7
WACC7.28%
ROIC/WACC0.88
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.26%
EPS 3Y18.79%
EPS 5YN/A
EPS Q2Q%41.66%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.07%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%3.24%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.87%
EBIT growth 3Y11.83%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y259.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.74%
OCF growth 3Y101.39%
OCF growth 5YN/A